These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 6854274

  • 1. Neutralizing and non-neutralizing monoclonal antibodies to the E2 glycoprotein of Semliki Forest virus can protect mice from lethal encephalitis.
    Boere WA, Benaissa-Trouw BJ, Harmsen M, Kraaijeveld CA, Snippe H.
    J Gen Virol; 1983 Jun; 64 (Pt 6)():1405-8. PubMed ID: 6854274
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The role of complement in monoclonal antibody-mediated protection against virulent Semliki Forest virus.
    Boere WA, Benaissa-Trouw BJ, Harmsen T, Erich T, Kraaijeveld CA, Snippe H.
    Immunology; 1986 Aug; 58(4):553-9. PubMed ID: 3015781
    [Abstract] [Full Text] [Related]

  • 5. Identification of distinct antigenic determinants on Semliki Forest virus by using monoclonal antibodies with different antiviral activities.
    Boere WA, Harmsen T, Vinjé J, Benaissa-Trouw BJ, Kraaijeveld CA, Snippe H.
    J Virol; 1984 Nov; 52(2):575-82. PubMed ID: 6208379
    [Abstract] [Full Text] [Related]

  • 6. Discrimination of the determinant specificity of two competitive Semliki Forest virus neutralizing monoclonal antibodies by anti-idiotypic antibodies.
    Oosterlaken TA, Kraaijeveld CA, Snijders A, Harmsen M, Benaissa-Trouw BJ, Snippe H.
    Arch Virol; 1988 Nov; 100(1-2):115-20. PubMed ID: 2455492
    [Abstract] [Full Text] [Related]

  • 7. A neutralization-inhibition enzyme immunoassay for anti-idiotypic antibodies that block monoclonal antibodies neutralizing Semliki Forest virus.
    Oosterlaken TA, Harmsen M, Tangerman C, Schielen P, Kraaijeveld CA, Snippe H.
    J Immunol Methods; 1988 Dec 09; 115(2):255-61. PubMed ID: 3058808
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A protective monoclonal anti-idiotypic vaccine to lethal Semliki Forest virus infection in BALB/c mice.
    Oosterlaken TA, Harmsen M, Jhagjhoor-Singh SS, Ekstijn GL, Kraaijeveld CA, Snippe H.
    J Virol; 1991 Jan 09; 65(1):98-102. PubMed ID: 1845911
    [Abstract] [Full Text] [Related]

  • 10. Homology of ab1 and ab3 monoclonal antibodies that neutralize Semliki Forest virus.
    Fernández IM, Bos NA, Harmsen M, Verheul AF, Snippe H, Kraaijeveld CA.
    Viral Immunol; 2001 Jan 09; 14(2):119-24. PubMed ID: 11398807
    [Abstract] [Full Text] [Related]

  • 11. Semliki Forest virus E2 envelope epitopes induce a nonneutralizing humoral response which protects mice against lethal challenge.
    Grosfeld H, Velan B, Leitner M, Cohen S, Lustig S, Lachmi BE, Shafferman A.
    J Virol; 1989 Aug 09; 63(8):3416-22. PubMed ID: 2473217
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Detection by a solid phase independent enzyme immunoassay of monoclonal anti-idiotypic antibodies against monoclonal antibodies neutralizing Semliki Forest virus and encephalomyocarditis virus.
    Harmsen M, Oosterlaken TA, Tangerman C, Snippe H, Kraaijeveld CA.
    J Virol Methods; 1993 Jul 09; 43(2):137-46. PubMed ID: 8396153
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antibody response to spike protein vaccines prepared from Semliki Forest virus.
    Balcarova J, Helenius A, Simons K.
    J Gen Virol; 1981 Mar 09; 53(Pt 1):85-92. PubMed ID: 6268742
    [Abstract] [Full Text] [Related]

  • 16. Role of immune responses in protection and pathogenesis during Semliki Forest virus encephalitis.
    Amor S, Scallan MF, Morris MM, Dyson H, Fazakerley JK.
    J Gen Virol; 1996 Feb 09; 77 ( Pt 2 )():281-91. PubMed ID: 8627232
    [Abstract] [Full Text] [Related]

  • 17. Serologically defined linear epitopes in the E2 envelope glycoprotein of Semliki Forest virus.
    Ariel N, Lehrer S, Elhanaty E, Sabo T, Brodt P, Lachmi B, Katz D, Levin R, Grosfeld H, Velan B.
    Arch Virol; 1990 Feb 09; 113(1-2):99-106. PubMed ID: 1696808
    [Abstract] [Full Text] [Related]

  • 18. Aspects of monoclonal antibody-mediated protection of mice against infection with virulent Semliki Forest virus.
    Boere WA, Kraaijeveld CA, Snippe H.
    Antiviral Res; 1985 Feb 09; Suppl 1():149-53. PubMed ID: 2417548
    [No Abstract] [Full Text] [Related]

  • 19. Influence of epitope polarity and adjuvants on the immunogenicity and efficacy of a synthetic peptide vaccine against Semliki Forest virus.
    Fernández IM, Snijders A, Benaissa-Trouw BJ, Harmsen M, Snippe H, Kraaijeveld CA.
    J Virol; 1993 Oct 09; 67(10):5843-8. PubMed ID: 7690411
    [Abstract] [Full Text] [Related]

  • 20. A vaccine against Semliki Forest virus consisting of a monoclonal anti-idiotypic antibody cross-linked to a protein which contains virus-specific T-helper cell epitopes.
    Kraaijeveld CA, Oosterlaken TA, Snijders A, Benaissa-Trouw BJ, Ekstijn GL, Snippe H.
    Antiviral Res; 1992 Oct 01; 19(4):275-84. PubMed ID: 1281391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.